- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07822269
Dental Loupe Versus Dental Operating Microscope for Non-Surgical Periodontal Treatment
Comparison of the Effectiveness of Dental Loupe and Dental Operating Microscope in Non-Surgical Periodontal Treatment
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tuğçe Paksoy, Associate Professor
- Phone Number: +905534490452
- Email: tugceakap86@hotmail.com
Study Locations
-
-
-
Ankara, Turkey (Türkiye)
- Not yet recruiting
- Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği Fakültesi
-
Contact:
- Seval Ceylan Şen, Assistant Professor
- Phone Number: +905333161232
- Email: dt.sceylan@hotmail.com
-
Contact:
- Özlem Saraç Atagün, Assistant Professor
- Phone Number: +905055096482
- Email: ozlemsarac2806@hotmail.com
-
Sub-Investigator:
- Gülbahar Ustaoğlu, Associate Professor
-
Kırklareli, Turkey (Türkiye)
- Not yet recruiting
- Kırklareli Üniversitesi Tıp Fakültesi Tıbbi Mikrobiyoloji Anabilim Dalı
-
Contact:
- Mehmet Demirci, Professor
- Phone Number: 05337106295
- Email: demircimehmet@hotmail.com
-
-
Üsküdar
-
Istanbul, Üsküdar, Turkey (Türkiye)
- Recruiting
- Sağlık Bilimleri Üniversitesi Hamidiye Diş Hekimliği Fakültesi
-
Contact:
- Tuğçe Paksoy, Associate Professor
- Phone Number: +905534490452
- Email: tugceakap86@hotmai.com
-
Contact:
- Alima Budakçı, PHd candidate
- Phone Number: +905319841597
- Email: alima-97@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being over 18 years of age
- Being systemically healthy
- Having at least 20 permanent teeth in both upper and lower jaws
- Having periodontitis
- Having the mental capacity to understand the research objectives and methods to be applied as explained in writing and orally
- Being convinced that the volunteer will be suitable and cooperative with the physician-patient before, during and after the procedure
- Not having any physical or psychological condition that would prevent mechanical debridement
- Not being a bacterial or viral carrier
Exclusion Criteria:
- Patients under 18 years of age
- Patients who are periodontally healthy
- Smoking more than 10 cigarettes a day
- Having received periodontal treatment within the last year
- Having used antibiotics within the last 3 months
- Being pregnant or breastfeeding
- Those with diabetes, chronic kidney failure, cancer, bleeding disorders, connective tissue diseases, and similar chronic diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dental Loupe
A split-mouth study design was planned for the same patient.
The patient's right or left upper or lower jaw would be treated with a dental loupe which determined by a coin toss.
Patients diagnosed with periodontitis (Stage 3-Grade A) in the periodontology clinic and undergoing routine non-surgical periodontal treatment would be included in the study if they voluntarily agreed to participate.
|
After clinical measurements are taken from Stage 3 Grade A periodontitis patients presenting to the periodontology clinic, a coin toss determines which area will undergo mechanical debridement under dental loupe magnification and which area under dental microscope magnification.
Before starting the procedure, a plaque sample will be collected from the deepest pathological pockets in the relevant area for later microbiological examination.
Following supragingival and subgingival debridement under local anesthesia using Gracey curettes and an ultrasonic scaler, patients will be placed in a follow-up period.
|
|
Experimental: Dental Microscope
A split-mouth study design was planned for the same patient.
The patient's right or left upper or lower jaw would be treated with a dental microscope which determined by a coin toss.
Patients diagnosed with periodontitis (Stage 3-Grade A) in the periodontology clinic and undergoing routine non-surgical periodontal treatment would be included in the study if they voluntarily agreed to participate.
|
After clinical measurements are taken from Stage 3 Grade A periodontitis patients presenting to the periodontology clinic, a coin toss determines which area will undergo mechanical debridement under dental loupe magnification and which area under dental microscope magnification.
Before starting the procedure, a plaque sample will be collected from the deepest pathological pockets in the relevant area for later microbiological examination.
Following supragingival and subgingival debridement under local anesthesia using Gracey curettes and an ultrasonic scaler, patients will be placed in a follow-up period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total microbial load
Time Frame: At enrollment. and 1 month control visit
|
To determine the amount of microorganisms, plaque samples taken from each patient will be stored in Eppendorf tubes at -80°C with sterile distilled water until microbial analysis is performed. Plaque samples stored at -80°C in Eppendorf tubes will be transported to the laboratories where microbiological examination will be performed using personal vehicles in dry ice thermal storage bags. DNA isolation from all suture samples will be performed using the High Pure PCR Template according to the manufacturer's instructions. The DNA will be stored at 80°C until the process is complete. The 16S rRNA gene will be detected by qPCR and the total bacterial count will be determined. Real-time PCR procedures will be performed on a LightCycler 480 II system using the Fast Start Essential DNA Green Master Mix Kit according to the manufacturer's instructions. |
At enrollment. and 1 month control visit
|
|
Probing Pocket Depth
Time Frame: At enrollment, 1 and 3 months control visits
|
Probing pocket depth, or probing depth, is a numerical value obtained by measuring the distance between the gingival margin and the gingival sulcus/pocket floor using a standard periodontal probe with a tip approximately 0.4-0.5 mm in diameter, and rounding the measurement to the nearest millimeter.
|
At enrollment, 1 and 3 months control visits
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gingival Index
Time Frame: At enrollment, 1 and 3 months control visits
|
This index was developed by Löe and Silness in 1963 and modified by various researchers in 1967. The system evaluates bleeding, the most fundamental sign of inflammation. The mesial, distal, vestibular, and lingual gingiva of the teeth are assessed. These values are then summed and divided by four to calculate the gingival index. Dividing the sum of these values by the number of teeth yields the individual score. 0 Healthy gingiva, no inflammation.
|
At enrollment, 1 and 3 months control visits
|
|
Papillary Bleeding Index
Time Frame: At enrollment, 1 and 3 months control visits
|
Probing is used to evaluate bleeding in the gingival papillae. Probing is performed on all four half-jaws. However, to ensure the evaluation reflects inflammation of all papillae and to facilitate the procedure, evaluation is performed on the papillae on the oral surfaces of the upper right and lower left jaws, and on the facial surfaces of the teeth in the upper left and lower right jaws. The values obtained are then divided by the total number of papillae to find the average papillary bleeding index value. This index is quite important for patient motivation. Patients who see bleeding in their gums can easily identify the diseased area in their mouth and develop positive behaviors in applying the oral care procedures they have been taught. Papillary Bleeding Index Values 0 No bleeding.
|
At enrollment, 1 and 3 months control visits
|
|
Plaque Index (PI/ Turesky Gilmore Glickman modification of the Quingley Hein plaque index)
Time Frame: At enrollment, 1 and 3 months control visits
|
The amount of plaque on facial and lingual surfaces is investigated using a plaque-staining agent. The total score is divided by the number of surfaces examined, and an index score is determined for the individual. The plaque-staining agent (Tri Plaque ID Gel™, GC Dental, USA) is applied to all tooth surfaces using a fine-tipped brush. Areas stained pink, purple, or blue on the tooth surfaces are scored from 0 to 5 (Score 0: no plaque, 1: independent plaque islands at the gingival margins, 2: thin bands of plaque at the gingival margins, 3: plaque covering no more than 1/3 of the tooth surface, 4: plaque covering no more than 2/3 of the tooth surface, 5: plaque covering more than 2/3 of the tooth surface). The entire mouth is divided into 6 different areas, and the average TQHPI values of the participants are calculated by taking the mathematical ratio of the values obtained from the mesial, distal, lingual, and vestibular surfaces of the specific teeth in each sextant. |
At enrollment, 1 and 3 months control visits
|
|
Gingival Bleeding Index (Ainamo & Bay)
Time Frame: At enrollment, 1 and 3 month control visits
|
This index assesses bleeding by gently probing within the gingival pocket.
The presence or absence of bleeding in the gingiva is evaluated based on the probing results.
A positive result is given if bleeding occurs within 10-15 seconds after probing the mesial, distal, vestibular, and lingual gingival areas of all teeth.
The ratio of the bleeding area to the examined area is expressed as a percentage.
|
At enrollment, 1 and 3 month control visits
|
|
Clinical attachment loss
Time Frame: At enrollment, 1 and 3 months control visits
|
This value is obtained by measuring the distance between the pocket base and the enamel-cementum junction using a standard periodontal probe with a diameter of 0.4-0.5 mm and rounding the measurement to the nearest millimeter value.
|
At enrollment, 1 and 3 months control visits
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25-25
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.